COVERA PLUS VASCULAR COVERED STENT SYSTEM UNK COVERA PLUS

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2020-02-24 for COVERA PLUS VASCULAR COVERED STENT SYSTEM UNK COVERA PLUS manufactured by Angiomed Gmbh & Co. Medizintechnik Kg.

Event Text Entries

[182333475] The catalog number identified has not been cleared in the us but is similar to the covera vascular stent graft products that are cleared in the us. The 510 k number and pro code for the covera vascular stent graft products are identified. As the lot number for the device was not provided, a manufacturing review could not be performed. The sample was not returned to the manufacturer for inspection/evaluation. Therefore, the investigation of the reported event is inconclusive. Based upon the available information, the definitive root cause for this event is unknown. The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device. Upon receipt of new or additional information, a follow-up report will be submitted as applicable. Journal article citation: gennai, s. , antonello, m. , leone, n. , migliari, m. , andreoli, f. , dall? Antonia, a. ,? Silingardi, r. (2019). Early experience with the covera stent graft as a bridging stent in branched thoraco-abdominal endovascular aneurysm repairs. Journal of vascular and interventional radiology, 30(12), 1949? 1955. Doi: 10. 1016/j. Jvir. 2019. 08. 006. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[182333476] It was reported in an article from the journal of vascular and international radiology (jvir) titled " early experience with the covera stent graft as a bridging stent in branched thoraco-abdominal endovascular aneurysm repairs " that after stent graft placement, on 30-day computed tomography angiography (cta) one type ic and four type ii endoleaks were diagnosed; type ic endoleak was successfully corrected with a distal extension. One patient with upper limb ischemia was corrected with endoluminal thrombectomy and stenting of the previous axillary access and another patient with splenic hemorrhage was managed with the deployment of a covered stent. Spinal cord ischemia was identified in 2 patients and contrast induced acute kidney injury was identified in 3 patients; 2 partially recovers and 1 required dialysis. The status of the patients was not provided.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9681442-2020-00052
MDR Report Key9746612
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2020-02-24
Date of Report2020-02-24
Date of Event2019-07-06
Date Mfgr Received2020-01-28
Date Added to Maude2020-02-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJUDITH LUDWIG
Manufacturer Street1415 W. 3RD STREET
Manufacturer CityTEMPE AZ 85281
Manufacturer CountryUS
Manufacturer Postal85281
Manufacturer Phone4803032689
Manufacturer G1ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
Manufacturer StreetWACHHAUSSTRASSE 6
Manufacturer CityKARLSRUHE 76227
Manufacturer CountryGM
Manufacturer Postal Code76227
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOVERA PLUS VASCULAR COVERED STENT SYSTEM
Generic NameVASCULAR COVERED STENT
Product CodePFV
Date Received2020-02-24
Catalog NumberUNK COVERA PLUS
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerANGIOMED GMBH & CO. MEDIZINTECHNIK KG
Manufacturer AddressWACHHAUSSTRASSE 6 KARLSRUHE 76227 GM 76227


Patients

Patient NumberTreatmentOutcomeDate
101. Other; 2. Required No Informationntervention 2020-02-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.